For example, HR-positive/HER2 negative (hormone receptor-positive and human epidermal growth factor receptor 2) breast cancers, which have the most favorable outcomes, are 23% higher in white women over the age of 20 years than Black women of the same ages, and 45% higher than in Hispanic and American Indian/Alaska Native women of those ages. This evidence concerns the gene ERBB2 and breast carcinoma.